Creato da XagenaMedicina il 15/10/2009

Xagena Medicina

Discussione di argomenti medico-farmacologici

 

« Neurology NewsMalattie rare & Biomedicina News »

Oncology News

Pazopanib
www.oncologyonline.net/?q=Pazopanib
A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from ...
 

Afinitor
www.oncologyonline.net/?q=Afinitor
Treatment with Everolimus ( Afinitor ) prolongs progression-free survival relative to placebo in patients with metastatic renal cell carcinoma who have ...
 

Nivolumab
www.oncologyonline.net/?q=Nivolumab
Bristol-Myers Squibb has announced long-term follow-up results ( median follow up of 20.3 months ) from the lung cancer cohort ( n=129 ) of the expanded ...
 

Epoetin alfa
www.oncologyonline.net/?q=Epoetin%20alfa
A study suggests that Aranesp ( Darbepoetin alfa ) administered every three weeks with intravenous ( IV ) iron has the potential to further enhance the ...

Ramucirumab
www.oncologyonline.net/?q=Ramucirumab
The results from the Phase III REGARD trial of Ramucirumab as a single agent in patients with advanced gastric cancer who have had disease progression after ...

 
 
 
Vai alla Home Page del blog
RSS (Really simple syndication) Feed Atom
 

AREA PERSONALE

 

ARCHIVIO MESSAGGI

 
 << Luglio 2024 >> 
 
LuMaMeGiVeSaDo
 
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31        
 
 

CERCA IN QUESTO BLOG

  Trova
 

FACEBOOK

 
 

FACEBOOK

 
 
Citazioni nei Blog Amici: 54
 

ULTIME VISITE AL BLOG

a_solitary_manprefazione09Alfa_Beta416161m12ps12acer.250Desert.69XagenaMedicinatiberis1santiago.gamboadony686marabertowiltuocognatino1cassetta2ilmondodiisidejonas21
 

CHI PUò SCRIVERE SUL BLOG

Solo l'autore può pubblicare messaggi in questo Blog e tutti gli utenti registrati possono pubblicare commenti.
I messaggi e i commenti sono moderati dall'autore del blog, verranno verificati e pubblicati a sua discrezione.
 
RSS (Really simple syndication) Feed Atom
 
 
 
 

© Italiaonline S.p.A. 2024Direzione e coordinamento di Libero Acquisition S.á r.l.P. IVA 03970540963